Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-01-29 06:10 am Purchase |
2020-12-31 | 13G | My Size, Inc. MYSZ |
Mitchell P. Kopin | 3,131 8.000% |
1,755![]() (+127.51%) |
Filing History |
2021-01-29 06:09 am Sale |
2020-12-31 | 13G | Intec Pharma Ltd NTEC |
Mitchell P. Kopin | 66,482 6.300% |
-1,255,459![]() (-94.97%) |
Filing History |
2021-01-29 06:07 am Purchase |
2020-12-31 | 13G | enVVeno Medical Corporation HJLI |
Mitchell P. Kopin | 191,431 7.000% |
29,614![]() (+18.30%) |
Filing History |
2021-01-29 06:05 am Purchase |
2020-12-31 | 13G | SENECA BIOPHARMA INC SNCA |
Mitchell P. Kopin | 1,176,852 6.400% |
759,851![]() (+182.22%) |
Filing History |
2021-01-25 06:04 am Purchase |
2021-01-14 | 13G | IT Tech Packaging, Inc. ITP |
Mitchell P. Kopin | 26,800 4.700% |
26,800![]() (New Position) |
Filing History |
2021-01-20 4:26 pm Purchase |
2020-12-01 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 2,316 5.700% |
2,316![]() (New Position) |
Filing History |
2021-01-19 06:06 am Purchase |
2020-01-07 | 13G | SOS Limited SOS |
Mitchell P. Kopin | 90,357 9.990% |
90,357![]() (New Position) |
Filing History |
2021-01-15 4:09 pm Purchase |
2020-01-06 | 13G | Atossa Therapeutics, Inc. ATOS |
Mitchell P. Kopin | 3,749,923 4.990% |
1,499,923![]() (+66.66%) |
Filing History |
2021-01-13 4:27 pm Purchase |
2021-01-07 | 13G | Hoth Therapeutics, Inc. HOTH |
Mitchell P. Kopin | 49,505 7.600% |
49,505![]() (New Position) |
Filing History |
2021-01-08 4:30 pm Unchanged |
2020-12-30 | 13G | Staffing 360 Solutions, Inc. STAF |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing |
2021-01-08 4:28 pm Purchase |
2020-12-30 | 13G | Histogen Inc. HSTO |
Mitchell P. Kopin | 50,000 3.600% |
50,000![]() (New Position) |
Filing History |
2020-12-28 06:15 am Purchase |
2020-12-17 | 13G | XWELL, Inc. XWEL |
Mitchell P. Kopin | 247,561 5.000% |
146,951![]() (+146.06%) |
Filing History |
2020-12-28 06:14 am Purchase |
2020-12-17 | 13G | Atossa Therapeutics, Inc. ATOS |
Mitchell P. Kopin | 2,250,000 4.900% |
2,150,032![]() (+2150.72%) |
Filing History |
2020-12-21 06:22 am Purchase |
2020-12-10 | 13G | ZW Data Action Technologies Inc. CNET |
Mitchell P. Kopin | 28,807 2.200% |
28,807![]() (New Position) |
Filing History |
2020-12-21 06:20 am Unchanged |
2020-12-10 | 13G | Xenetic Biosciences, Inc. XBIO |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing History |
2020-12-17 4:36 pm Purchase |
2020-12-08 | 13G | Neovasc Inc. NVCN |
Mitchell P. Kopin | 51,391 4.300% |
31,214![]() (+154.70%) |
Filing History |
2020-12-17 4:34 pm Purchase |
2020-12-08 | 13G | Singularity Future Technology Ltd. SGLY |
Mitchell P. Kopin | 32,007 5.200% |
32,007![]() (New Position) |
Filing History |
2020-11-30 06:12 am Purchase |
2020-11-20 | 13G | Tantech Holdings Ltd TANH |
Mitchell P. Kopin | 158 4.100% |
158![]() (New Position) |
Filing History |
2020-11-20 4:06 pm Purchase |
2020-11-17 | 13G | TNF Pharmaceuticals, Inc. TNFA |
Mitchell P. Kopin | 24,324 7.500% |
24,321![]() (+748340.00%) |
Filing History |
2020-11-09 06:04 am Purchase |
2020-10-30 | 13G | Titan Pharmaceuticals, Inc. TTNP |
Mitchell P. Kopin | 6 0.001% |
6![]() (New Position) |
Filing History |